NCT06786754View on ClinicalTrials.gov

Fibroblasts and Thoracic Aortic Aneurysms: in Vitro Characterization in With Marfan Syndrome and Genetic Aortic Diseases

Enrolling by invitationOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

June 17, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

February 28, 2026

Conditions
Rare DiseasesThoracic Aortic Aneurysm (TAA)Marfan Syndrome
Trial Locations (1)

20097

Cardiovascular Genetic Centre IRCCS Policlinico San Donato, San Donato Milanese

All Listed Sponsors
collaborator

University of Milan

OTHER

lead

IRCCS Policlinico S. Donato

OTHER